Supported by the Wellcome Trust Sanger Institute, the Cancer Genome Project (CGP) “”is using the human genome sequence and high throughput mutation detection techniques to identify somatically acquired sequence variants/mutations and hence identify genes critical in the development of human cancers. This initiative will ultimately provide the paradigm for the detection of germline mutations in non-neoplastic human genetic diseases through genome-wide mutation detection approaches.”” The CGP website links to a number of Data Resources including the Cancer Gene Census, Cancer Cell Line Project, Catalogue of Somatic Mutations in Cancer (reported on in the March 4, 2005 NSDL Scout Report for Life Sciences), Somatic Mutations in Protein Kinase Genes, and more. The site also contains an extensive listing of publications from 1998 to 2004 with links to PubMed Abstracts.